NCT05410951View on ClinicalTrials.gov

LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

May 16, 2027

Conditions
Lobular Breast CarcinomaLobular in Situ Breast CarcinomaBRCA1 MutationBRCA2 Mutation
Interventions
DIAGNOSTIC_TEST

Illumina panel

"Determination of germline mutations using a recent panel including 113 genes from the Illumina protocol"

Trial Locations (1)

Unknown

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER